PHIBRO ANIMAL HEALTH CORP-A (PAHC) Fundamental Analysis & Valuation

NASDAQ:PAHC • US71742Q1067

49.47 USD
+0.47 (+0.96%)
At close: Mar 13, 2026
49.47 USD
0 (0%)
After Hours: 3/13/2026, 4:30:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This PAHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, PAHC scores 6 out of 10 in our fundamental rating. PAHC was compared to 193 industry peers in the Pharmaceuticals industry. PAHC scores excellent on profitability, but there are some minor concerns on its financial health. PAHC is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make PAHC a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. PAHC Profitability Analysis

1.1 Basic Checks

  • In the past year PAHC was profitable.
  • In the past year PAHC had a positive cash flow from operations.
  • PAHC had positive earnings in each of the past 5 years.
  • Each year in the past 5 years PAHC had a positive operating cash flow.
PAHC Yearly Net Income VS EBIT VS OCF VS FCFPAHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • The Return On Assets of PAHC (6.55%) is better than 87.56% of its industry peers.
  • The Return On Equity of PAHC (27.71%) is better than 93.78% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.16%, PAHC belongs to the best of the industry, outperforming 92.23% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PAHC is below the industry average of 13.21%.
  • The 3 year average ROIC (8.29%) for PAHC is below the current ROIC(13.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.55%
ROE 27.71%
ROIC 13.16%
ROA(3y)2.38%
ROA(5y)3.78%
ROE(3y)9.79%
ROE(5y)14.19%
ROIC(3y)8.29%
ROIC(5y)8.41%
PAHC Yearly ROA, ROE, ROICPAHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • PAHC's Profit Margin of 6.29% is amongst the best of the industry. PAHC outperforms 82.90% of its industry peers.
  • In the last couple of years the Profit Margin of PAHC has declined.
  • PAHC has a Operating Margin of 12.78%. This is amongst the best in the industry. PAHC outperforms 85.49% of its industry peers.
  • PAHC's Operating Margin has improved in the last couple of years.
  • PAHC has a Gross Margin (32.56%) which is comparable to the rest of the industry.
  • PAHC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.78%
PM (TTM) 6.29%
GM 32.56%
OM growth 3Y8.12%
OM growth 5Y4.74%
PM growth 3Y-10.66%
PM growth 5Y-2.37%
GM growth 3Y1.41%
GM growth 5Y-0.32%
PAHC Yearly Profit, Operating, Gross MarginsPAHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. PAHC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PAHC is creating some value.
  • PAHC has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PAHC remains at a similar level compared to 5 years ago.
  • Compared to 1 year ago, PAHC has a worse debt to assets ratio.
PAHC Yearly Shares OutstandingPAHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
PAHC Yearly Total Debt VS Total AssetsPAHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • PAHC has an Altman-Z score of 3.40. This indicates that PAHC is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.40, PAHC is doing good in the industry, outperforming 69.43% of the companies in the same industry.
  • The Debt to FCF ratio of PAHC is 15.46, which is on the high side as it means it would take PAHC, 15.46 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 15.46, PAHC is in the better half of the industry, outperforming 76.17% of the companies in the same industry.
  • A Debt/Equity ratio of 2.14 is on the high side and indicates that PAHC has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 2.14, PAHC is doing worse than 76.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF 15.46
Altman-Z 3.4
ROIC/WACC1.43
WACC9.18%
PAHC Yearly LT Debt VS Equity VS FCFPAHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • PAHC has a Current Ratio of 3.05. This indicates that PAHC is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.05, PAHC is in line with its industry, outperforming 53.37% of the companies in the same industry.
  • A Quick Ratio of 1.22 indicates that PAHC should not have too much problems paying its short term obligations.
  • PAHC has a worse Quick ratio (1.22) than 70.47% of its industry peers.
Industry RankSector Rank
Current Ratio 3.05
Quick Ratio 1.22
PAHC Yearly Current Assets VS Current LiabilitesPAHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PAHC Growth Analysis

3.1 Past

  • PAHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.91%, which is quite impressive.
  • The Earnings Per Share has been growing by 14.12% on average over the past years. This is quite good.
  • The Revenue has grown by 32.39% in the past year. This is a very strong growth!
  • PAHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.12% yearly.
EPS 1Y (TTM)73.91%
EPS 3Y19.98%
EPS 5Y14.12%
EPS Q2Q%61.11%
Revenue 1Y (TTM)32.39%
Revenue growth 3Y11.21%
Revenue growth 5Y10.12%
Sales Q2Q%20.89%

3.2 Future

  • PAHC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.85% yearly.
  • The Revenue is expected to decrease by -2.45% on average over the next years.
EPS Next Y47.63%
EPS Next 2Y28.15%
EPS Next 3Y21.85%
EPS Next 5YN/A
Revenue Next Year16.33%
Revenue Next 2Y9.9%
Revenue Next 3Y7.61%
Revenue Next 5Y-2.45%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PAHC Yearly Revenue VS EstimatesPAHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
PAHC Yearly EPS VS EstimatesPAHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. PAHC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 17.67, which indicates a rather expensive current valuation of PAHC.
  • PAHC's Price/Earnings ratio is rather cheap when compared to the industry. PAHC is cheaper than 84.46% of the companies in the same industry.
  • PAHC is valuated rather cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.41, PAHC is valued correctly.
  • Based on the Price/Forward Earnings ratio, PAHC is valued cheaper than 83.94% of the companies in the same industry.
  • PAHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.82.
Industry RankSector Rank
PE 17.67
Fwd PE 14.41
PAHC Price Earnings VS Forward Price EarningsPAHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PAHC is valued cheaply inside the industry as 86.53% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, PAHC is valued a bit cheaper than 76.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.4
EV/EBITDA 11.03
PAHC Per share dataPAHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PAHC has an outstanding profitability rating, which may justify a higher PE ratio.
  • PAHC's earnings are expected to grow with 21.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)1.25
EPS Next 2Y28.15%
EPS Next 3Y21.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. PAHC Dividend Analysis

5.1 Amount

  • PAHC has a yearly dividend return of 0.97%, which is pretty low.
  • PAHC's Dividend Yield is rather good when compared to the industry average which is at 0.71. PAHC pays more dividend than 90.16% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, PAHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

  • The dividend of PAHC has a limited annual growth rate of 0.02%.
  • PAHC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • PAHC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.02%
Div Incr Years0
Div Non Decr Years10
PAHC Yearly Dividends per sharePAHC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4

5.3 Sustainability

  • PAHC pays out 21.13% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of PAHC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.13%
EPS Next 2Y28.15%
EPS Next 3Y21.85%
PAHC Yearly Income VS Free CF VS DividendPAHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M
PAHC Dividend Payout.PAHC Dividend Payout, showing the Payout Ratio.PAHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PAHC Fundamentals: All Metrics, Ratios and Statistics

PHIBRO ANIMAL HEALTH CORP-A

NASDAQ:PAHC (3/13/2026, 4:30:03 PM)

After market: 49.47 0 (0%)

49.47

+0.47 (+0.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners96.96%
Inst Owner Change-3.31%
Ins Owners0.6%
Ins Owner Change11.65%
Market Cap2.01B
Revenue(TTM)1.46B
Net Income(TTM)92.09M
Analysts48.89
Price Target46.24 (-6.53%)
Short Float %5.23%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.48
Dividend Growth(5Y)0.02%
DP21.13%
Div Incr Years0
Div Non Decr Years10
Ex-Date03-04
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.14%
Min EPS beat(2)14.97%
Max EPS beat(2)27.3%
EPS beat(4)4
Avg EPS beat(4)17.13%
Min EPS beat(4)7.47%
Max EPS beat(4)27.3%
EPS beat(8)8
Avg EPS beat(8)19.67%
EPS beat(12)9
Avg EPS beat(12)9.55%
EPS beat(16)10
Avg EPS beat(16)3.77%
Revenue beat(2)2
Avg Revenue beat(2)2.95%
Min Revenue beat(2)2.82%
Max Revenue beat(2)3.07%
Revenue beat(4)3
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-3.24%
Max Revenue beat(4)3.07%
Revenue beat(8)6
Avg Revenue beat(8)1.55%
Revenue beat(12)7
Avg Revenue beat(12)0.18%
Revenue beat(16)10
Avg Revenue beat(16)0.46%
PT rev (1m)5.43%
PT rev (3m)5.43%
EPS NQ rev (1m)4.78%
EPS NQ rev (3m)4.78%
EPS NY rev (1m)10.4%
EPS NY rev (3m)10.4%
Revenue NQ rev (1m)0.34%
Revenue NQ rev (3m)0.34%
Revenue NY rev (1m)1.47%
Revenue NY rev (3m)1.47%
Valuation
Industry RankSector Rank
PE 17.67
Fwd PE 14.41
P/S 1.37
P/FCF 42.4
P/OCF 21.54
P/B 6.03
P/tB 8.37
EV/EBITDA 11.03
EPS(TTM)2.8
EY5.66%
EPS(NY)3.43
Fwd EY6.94%
FCF(TTM)1.17
FCFY2.36%
OCF(TTM)2.3
OCFY4.64%
SpS36.13
BVpS8.2
TBVpS5.91
PEG (NY)0.37
PEG (5Y)1.25
Graham Number22.73
Profitability
Industry RankSector Rank
ROA 6.55%
ROE 27.71%
ROCE 16.66%
ROIC 13.16%
ROICexc 14.09%
ROICexgc 15.46%
OM 12.78%
PM (TTM) 6.29%
GM 32.56%
FCFM 3.23%
ROA(3y)2.38%
ROA(5y)3.78%
ROE(3y)9.79%
ROE(5y)14.19%
ROIC(3y)8.29%
ROIC(5y)8.41%
ROICexc(3y)9.26%
ROICexc(5y)9.5%
ROICexgc(3y)10.65%
ROICexgc(5y)11.26%
ROCE(3y)10.49%
ROCE(5y)10.64%
ROICexgc growth 3Y1.17%
ROICexgc growth 5Y-1.23%
ROICexc growth 3Y4.48%
ROICexc growth 5Y1.99%
OM growth 3Y8.12%
OM growth 5Y4.74%
PM growth 3Y-10.66%
PM growth 5Y-2.37%
GM growth 3Y1.41%
GM growth 5Y-0.32%
F-Score7
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF 15.46
Debt/EBITDA 2.99
Cap/Depr 90.23%
Cap/Sales 3.13%
Interest Coverage 250
Cash Conversion 39.13%
Profit Quality 51.35%
Current Ratio 3.05
Quick Ratio 1.22
Altman-Z 3.4
F-Score7
WACC9.18%
ROIC/WACC1.43
Cap/Depr(3y)116.74%
Cap/Depr(5y)111.08%
Cap/Sales(3y)4.1%
Cap/Sales(5y)3.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.91%
EPS 3Y19.98%
EPS 5Y14.12%
EPS Q2Q%61.11%
EPS Next Y47.63%
EPS Next 2Y28.15%
EPS Next 3Y21.85%
EPS Next 5YN/A
Revenue 1Y (TTM)32.39%
Revenue growth 3Y11.21%
Revenue growth 5Y10.12%
Sales Q2Q%20.89%
Revenue Next Year16.33%
Revenue Next 2Y9.9%
Revenue Next 3Y7.61%
Revenue Next 5Y-2.45%
EBIT growth 1Y82.86%
EBIT growth 3Y20.25%
EBIT growth 5Y15.34%
EBIT Next Year86.98%
EBIT Next 3Y28.38%
EBIT Next 5Y2.18%
FCF growth 1Y27.7%
FCF growth 3YN/A
FCF growth 5Y10.58%
OCF growth 1Y25.35%
OCF growth 3Y36.29%
OCF growth 5Y6.19%

PHIBRO ANIMAL HEALTH CORP-A / PAHC FAQ

Can you provide the ChartMill fundamental rating for PHIBRO ANIMAL HEALTH CORP-A?

ChartMill assigns a fundamental rating of 6 / 10 to PAHC.


What is the valuation status of PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock?

ChartMill assigns a valuation rating of 7 / 10 to PHIBRO ANIMAL HEALTH CORP-A (PAHC). This can be considered as Undervalued.


Can you provide the profitability details for PHIBRO ANIMAL HEALTH CORP-A?

PHIBRO ANIMAL HEALTH CORP-A (PAHC) has a profitability rating of 8 / 10.


What is the financial health of PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock?

The financial health rating of PHIBRO ANIMAL HEALTH CORP-A (PAHC) is 5 / 10.


What is the expected EPS growth for PHIBRO ANIMAL HEALTH CORP-A (PAHC) stock?

The Earnings per Share (EPS) of PHIBRO ANIMAL HEALTH CORP-A (PAHC) is expected to grow by 47.63% in the next year.